NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹45 Cr | ₹46 Cr | ₹41 Cr | ₹20 Cr | ₹17 Cr |
What is the latest Capital Work in Progress ratio of NEULAND LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹20 Cr |
| Mar2021 | ₹17 Cr |
How is Capital Work in Progress of NEULAND LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | -2.92 | |
| Mar2024 | ₹46 Cr | 13.13 | |
| Mar2023 | ₹41 Cr | 98.30 | |
| Mar2022 | ₹20 Cr | 18.59 | |
| Mar2021 | ₹17 Cr | - | |
Compare Capital Work in Progress of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹15,366.1 Cr | -2% | -11.8% | 11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -2% |
-11.8% |
11.8% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses